On 27 July, MediciNova, Inc., (NASDAQ:MNOV) announced that FDA (U.S. Food and Drug Administration) has approved a second protocol for a clinical trial evaluating MN-001 (tipelukast) for a NASH indication. This study targets NASH patients with hypertriglyceridemia to evaluate the ability of MN-001 to improve cardiovascular risk by assessing cholesterol-efflux capacity and serum triglyceride levels as well as reduction of percent fat in the liver, as assessed by MRI. MediciNova Inc. (NASDAQ:MNOV) belongs to Healthcare sector. Its weekly performance is -2.44%. On last trading day company shares ended up $3.60. MediciNova Inc. (NASDAQ:MNOV) distance from 50-day simple moving average (SMA50) is -7.94%.
Cytori Therapeutics, Inc. (NASDAQ:CYTX) continued to reduce its operating cash burn, spending approximately $4.8 million in the second quarter 2015, compared to $9.2 million in Q2 2014. Second quarter 2015 net income allocable to common stockholders was $4.5 million (or a net loss of $8.7 million and $0.06 per share when excluding a non-cash charge of $13.1 million related to the change in fair value of warrant liabilities) compared to $11.8 million (or $0.15 per share) for the same period in 2014. Cytori Therapeutics, Inc. (NASDAQ:CYTX) shares moved down -2.38% in last trading session and ended the day at $0.41. CYTX Gross Margin is 63.50% and its return on assets is -167.60%. Cytori Therapeutics, Inc. (NASDAQ:CYTX) quarterly performance is -40.58%.
Nova LifeStyle, Inc. (NASDAQ: NVFY) announced that the Company will release its financial results for the second quarter and six months ended June 30, 2015, before the opening of the stock market on Wednesday, August 12, 2015. On 06 August, Nova Lifestyle, Inc. (NASDAQ:NVFY) shares advanced 1.26% and was closed at $2.43. NVFY EPS growth in last 5 year was 10.90%. Nova Lifestyle, Inc. (NASDAQ:NVFY) year to date (YTD) performance is -13.52%.
On 3 August, Eagle Materials Inc. (NYSE:EXP) reported fiscal first-quarter profit of $37.8 million. The Dallas-based company said it had net income of 75 cents per share. The results fell short of Wall Street expectations. The average estimate of four analysts surveyed by Zacks Investment Research was for earnings of 88 cents per share.Eagle Materials Inc. (NYSE:EXP) ended the last trading day at $79.73. Company weekly volatility is calculated as 4.56% and price to cash ratio as 533.98. Eagle Materials Inc. (NYSE:EXP) showed a weekly performance of 3.09%.
On 3 August, iRobot Corporation (NASDAQ: IRBT) has received a $9.8 million order from the U.S. Marine Corps Systems Command for 75 SUGV robot systems. All deliveries under the order will be completed by Q2 2016.iRobot Corporation (NASDAQ:IRBT) shares moved down -1.38% in last trading session and ended the day at $30.01. IRBT Gross Margin is 47.10% and its return on assets is 7.60%. iRobot Corporation (NASDAQ:IRBT) quarterly performance is -8.51%.